U.S. Nuclear Is Advancing 5 Super Technologies that Can Help Our Planet and Save Lives

Fusion Energy

 

In 2016, when U.S. Nuclear Corp. (UCLE: OTC) announced their investments in MIFTI and MIFTEC, the most advanced Fusion Energy technology ever developed, the share price exploded from 24 cents to $5.00.  Like all good things, it has taken several years to develop this world changing technology, but today there is reason for shareholders to cheer again.  See MIFTI Intro that explains why MIFTI is the unrivaled leader in fusion energy and why it is so close to commercial development.

 

Few investors understand how significant this technology is and how valuable it is about to become.  The MIFTI Fusion Generator uses an isotope of hydrogen from ordinary seawater that costs $6/gallon to make.  MIFTI’s Fusion Generator converts one gallon of seawater into the same amount of energy as 300 gallons of gasoline.  It is very difficult to put a number on the value of a technology that can change our world so soon and so dramatically.  This technology has demonstrated the potential to provide the entire planet with clean, safe, unlimited very low-cost energy for millions of years to come.  And it is expected to be ushered in before 2030.

 

Interested investors are encouraged to be watching for news that is expected before year end.  MIFTI expects to be announcing world-changing results validated by Lawrence Livermore Labs this October and December at 2 internationally known fusion conferences.

 

Energy is one of the largest industries in the world.

 

PFAS Contaminants

​

A recent USGS study found that nearly half of U.S. households nationwide are contaminated with PFAS, a group of chemicals linked to cancer and new diseases never heard of before.  With PFAS contamination so prevalent, it is crucial to monitor and identify where the contamination is present/coming from.  Fortunately, US Nuclear Corp. (OTCQB: UCLE) now offers two unique products that can identify and measure PFOA and PFOS down to 1 ppt in less than a few minutes (note the EPA’s proposed regulation limit for PFOA and PFOS is 4 ppt), whereas a laboratory analysis may take weeks. 

​

The PFAS contamination study was conducted over 5 years and sampled over 700 locations across the country, specifically collecting water from homeowners taps where exposure actually occurs.  The USGS said that the EPA’s PFOA and PFOS limit of 4ppt was ‘exceeded in every sample in which they were detected in’.  The EPA recommends finding out what chemicals are in your drinking water and conducting regular testing to compare to the standards for safe levels.  Researchers recently estimated that exposure to PFAS contamination may have contributed to 6.5 million deaths in the U.S. between 1999-2018, mostly due to cancer and heart disease. 

​

US Nuclear’s new PFAS monitors are ideal for everyone concerned about unsafe levels, including homeowners, commercial real estate, water utilities, and manufacturing and distribution.

​

Available in both portable and benchtop versions, US Nuclear’s Model PFAS-TA uses a proprietary Surface Acoustic Wave (SAW) detector to identify and measure PFAS contamination and is the only monitor on the market that can measure down to 1 ppt in just 5-60 seconds.  The PFAS-TA can be used for rapid, on-the-spot PFAS contamination testing below the EPA’s limit and can be configured for either water or air samples.

​

Currently, there are no PFAS monitoring or detection devices available.  U.S.Nuclear’s device appears to be the first to market . . . and based on the number of about 500,000 PFAS collection devices currently in use and with no way to tell if they are working or not, there could be a multi-billion dollar market waiting for U.S. Nuclear’s PFAS monitors.

​

Radioisotopes

​

In 2018, this article, “Why U.S. Nuclear and MIFTEC Will Win the $17 Billion Radioisotope Race” appeared in Seeking Alpha.

US Nuclear has positioned itself with the world’s leader in nuclear fusion to become a dominant provider of scarce, costly, and essential radioisotopes used to diagnose cancer and heart disease and to treat cancer with cobalt 50. If successful, as is expected by MIFTI/MIFTEC and US Nuclear, sales and shares of US Nuclear could be impacted greatly.

​

U.S. Nuclear and MIFTEC generators can produce the highest quality radioisotopes for less than half the current cost of fission reactors.  There is no costly radioactive waste.  And MIFTEC expects their first generators to be commercially available in 3 years after funding which is happening in stages now.  The market for radioisotopes is grossly underserved and is estimated at about $17 billion per year.

​

New Generation Ultra-Super Capacitors

​

This press release reveals a new generation super capacitor that can change the world, “US Nuclear and Grapheton’s New Supercapacitors Could Charge Your Next Electric Vehicle in Seconds”.  US Nuclear’s (OTCQB: UCLE) partner Grapheton has developed the next generation of supercapacitors using a special patented glassy carbon material. Featuring remarkable charge storage capacity and power density, Grapheton’s supercapacitors could be used in powering and rapidly charging electric vehicle systems. A typical electric vehicle running on lithium-ion batteries takes about 8 hours to fully charge, but a supercapacitor system could be fully charged in under a minute. Batteries still retain the advantage when it comes to higher energy density (ability to store energy), but new advances in supercapacitor technology, such as those made by Grapheton, could allow supercapacitors to hold the same amount of charge as a battery and deliver the charge in just seconds. Grapheton’s unique glassy carbon supercapacitors can have up to 3 million times more capacitance than commercial off-the-shelf capacitors.

​

Grapheton’s Glassy Carbon Super Capacitor is so small and so thin that they have the potential to replace hundreds of capacitors on electronic circuit boards.  For example, the typical smart phone has several hundred capacitors in its’ circuit board that can be eliminated and built into the microchips with a layer so thin that this will bring about the next generation of electronic miniaturization.  

Grapheton and U.S. Nuclear are accelerating development of the new super capacitor.

​

New Desalination Technology

​

US Nuclear Corp. (OTC-QB: UCLE) and Arbok-Nuclear (an NTAC company), have recently formed a highly beneficial Strategic Alliance for the purpose of bringing to market amazing improvements to desalination plants and rad-wastewater treatment. 

20% of the world’s population do not have adequate access to safe drinking water. We all know that access to safe drinking water is a huge problem in undeveloped areas with poor sanitation and also rich desert areas and big cities as well. Desalination projects are often paired with nuclear power plants and can be symbiotic. The power plant provides the needed electricity and the waste heat facilitates the desalination process, while the desalination plant provides fresh, clean cooling water. Arbok Nuclear has developed patented technology to remove dangerous radioisotopes from NPP cooling and process water, waste water, and other water sources, in addition to providing desalination technology which is 30% less costly and has double the output than traditional technologies. Arbok’s desalination plant produces pure drinking quality water useful to the NPPs for cooling, and does so at a fraction of the price using as much as 10 times less energy than reverse osmosis. With reverse osmosis, 50% or more of the water taken from the sea, is transformed into a toxic brine, but Arbok has no waste and 100% of the water is desalinated while the salt and other contaminants are collected as a dry powder which can be easily disposed of. Notably, Arbok’s purification method is the only one available that can remove ALL radioisotopes, even including tritium, which has been a large issue with the Fukushima releases. Arbok’s radioisotope removal and desalination technology has been tested at multiple NPPs and research institutes and was determined to fully meet the requirements for use.

​

Conclusion

​

All the above technological products that U.S. Nuclear Corp. is developing, have the potential to be game-changers.

U.S. Nuclear Corp. has a very small market cap of under $2 million and if just one of these 5 promising technologies is just partially successful, the impact to US Nuclear share price could be dramatic.  U.S. Nuclear is a very promising small company with a big future that deserves to be on everybody’s watch list.

​

Legal Disclosures and Disclaimers

Green Planet Microcaps is not a registered investment adviser. The information that we provide from our website or newsletters is not, and should not be construed in any manner, to be investment advice. All opinions and information provided on this site are for educational and research purposes. Green Planet Microcaps encourages all readers to do their own due diligence and research when determining which investment strategies are best suited for them or to seek the advice of an investment professional.

​

Any information provided by Green Planet Microcaps should not be construed by any subscriber or prospective subscriber as a solicitation by Green Planet Microcaps to effect, or attempt to effect, any transaction in any security. Investments in the securities markets, and especially in private securities of small start-up companies, are incredibly and highly speculative and involve substantial risk that your entire investment could be lost. The information that we provide or that is derived from our website and/or newsletters should not be a substitute for advice from an investment professional. We encourage you to obtain personal advice from your professional investment advisor and to make independent investigations before acting on the information that you obtain from Green Planet Microcaps or derive from our website and/or newsletters. Only you can determine what level of risk is appropriate for you.

​

Specifically, we advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to purchase or trade in stocks or any securities presented on this website and/or in a particular newsletter. All information provided regarding the companies featured comes from the companies themselves, SEC filings, news releases, private placement memoranda, company websites as well as other sources of publicly available information. The profiles of these highlighted public and private companies are not in any way a solicitation or recommendation to buy, sell, or hold these or any other securities.

​

Most of the information on our website and/or newsletters or that we otherwise provide is derived directly from information published by the companies on which we report and/or from other sources we believe are reliable, without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. The information may contain discussions of, or provide access to, certain positions and recommendations as of a specific date. Due to various factors, including, but not limited to, changing market conditions, such discussions and positions/recommendations may no longer be reflective of current discussions and positions/recommendations. We do not in any way warrant or guarantee the success of nor endorse any action which you take in reliance on the information that we provide or that is derived from our website.

​

Investors should not rely solely on the information contained on this website or in any specific newsletter. Rather, investors should use the information contained on this Website and/or in newsletters as a starting point for doing additional independent research on the featured private and public companies. The advertisements within this newsletter are not to be construed as offers to purchase securities in the companies which may be the subject of such advertisements pursuant to federal or state law or the laws of any foreign jurisdiction.

Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects’”, “will,” “anticipates,” “estimates,” “believes,” “understands” or that by statements indicating certain actions “may,” “could,” or “might” occur. There is no guarantee past performance will be indicative of future results. The accuracy or completeness of the information in this newsletter is only as reliable as the sources they were obtained from.

​

Green Planet Microcaps was compensated $5,000 for this article also owns restricted shares of US Nuclear and will not be liable for any consequential, incidental, punitive, special, exemplary or indirect damages resulting directly or indirectly from the use of or reliance upon any material provided by Green Planet Microcaps or derived from Green Planet Microcap’s website and/or newsletters. Green Planet Microcaps shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscriber’s inability to use or any delay in accessing Green Planet Microcaps website or any other source of material provided by Green Planet Microcaps including newsletters; (3) any absence of material on Green Planet Microcaps; (4) Green Planet Microcaps failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material. Green Planet Microcaps and each subscriber acknowledge that, without limitation, the above-enumerated conditions cannot be the probable result of any breach of any agreement between Green Planet Microcaps and the subscriber.

​

Green Planet Microcaps is not affiliated with any brokerage firm and does not endorse or recommend any specific brokerage firm. Green Planet Microcaps is not and will not be responsible for any trades made by a broker on the subscriber’s behalf under any circumstances.

​

​

​

​

​